AI-driven drug discovery and synthesis

Targeting prion disease reversal via CRISPR-based gene editing and chaperone proteins

neurodegenerative diseases gene therapy protein misfolding CRISPR therapeutic interventions

For automated retrosynthesis with AI-driven molecular pathway optimization

automated retrosynthesis AI-driven optimization molecular pathways organic synthesis chemical planning

For senolytic drug discovery using CRISPR-enabled zombie cell targeting

senolytics CRISPR screening aging therapeutics zombie cells drug discovery

Decoding synaptic vesicle recycling defects in early-stage Parkinson's disease with super-resolution microscopy

synaptic vesicles STED microscopy alpha-synuclein presynaptic dysfunction neurodegenerative biomarkers

Accelerating drug discovery via reaction prediction transformers in organic synthesis

reaction prediction transformers drug discovery organic synthesis AI pharmaceuticals

Accelerating drug discovery using reaction prediction transformers for retrosynthetic analysis

reaction prediction transformers retrosynthesis drug discovery AI-driven chemistry

Unraveling protein folding mechanics using knot theory and molecular dynamics

knot theory protein folding biophysics molecular dynamics neurodegenerative diseases

Through autonomous lab assistants for accelerated drug discovery pipelines

autonomous labs drug discovery AI robotics high-throughput screening pharmaceutical synthesis

Integrating neutrino physics with medical imaging for early cancer detection

neutrino imaging cancer diagnostics particle physics medical technology early detection

Optimizing viral vector production for gene therapy using high-throughput microfluidics

viral vectors gene therapy microfluidics AAV production high-throughput screening

Employing retrieval-augmented generation to accelerate drug repurposing for rare diseases

retrieval-augmented generation drug repurposing rare diseases AI pharmaceuticals

Investigating inflammasome inhibition as a therapeutic strategy for age-related neurodegenerative diseases

inflammasome neuroinflammation neurodegeneration therapeutic targets aging